Catalyst Wire Dossier Catalyst Wire Dossier

SEL-037 (Pegsiticase)

Pegsiticase · Selecta Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SEL-037 (Pegsiticase), covering 2016-10-21 to 2016-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels [Phase 1]

See pricing